Earnings Call · Q1 FY2025·2025-05-13

Q1 25EPS 0.00%·Rev n/aQ4 24EPS +54.55%·Rev n/aQ3 24EPS +25.00%·Rev n/aQ2 24EPS -100.00%*·Rev n/a⚠ consensus missing

Vaxart, Inc. VXRT

Ed Berg — SVP, General Counsel

Steven Lo — President, Chief Exec Officer

James Cummings — Chief Medical Officer

Sean Tucker — SVP, Chief Scientific Officer

Phillip Lee — Chief Financial Officer

−3.7%1d on move date−3.9% vs SPY3d+21.6%5d+22.3%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VXRT calls or request research access.

More VXRT calls Browse calls Request research access